Cargando…
Effect of Adenomatous Polyposis Coli Loss on Tumorigenic Potential in Pancreatic Ductal Adenocarcinoma
Loss of the Adenomatous Polyposis Coli (APC) tumor suppressor in colorectal cancer elicits rapid signaling through the Wnt/β-catenin signaling pathway. In contrast to this well-established role of APC, recent studies from our laboratory demonstrated that APC functions through Wnt-independent pathway...
Autores principales: | Cole, Jennifer M., Simmons, Kaitlyn, Prosperi, Jenifer R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6770120/ https://www.ncbi.nlm.nih.gov/pubmed/31540078 http://dx.doi.org/10.3390/cells8091084 |
Ejemplares similares
-
Adenomatous Polyposis Coli Gene Mutations in 22 Chinese Pedigrees with Familial Adenomatous Polyposis
por: Wang, Dan, et al.
Publicado: (2019) -
Adenomatous Polyposis Coli loss controls cell cycle regulators and response to paclitaxel in MDA-MB-157 metaplastic breast cancer cells
por: Astarita, Emily M., et al.
Publicado: (2021) -
Immunopurification of adenomatous polyposis coli (APC) proteins
por: Elliott, Kerryn L, et al.
Publicado: (2013) -
Adenomatous polyposis coli in cancer and therapeutic implications
por: Noe, Olivia, et al.
Publicado: (2021) -
Synonymous mutation adenomatous polyposis coli(Δ486s) affects exon splicing and may predispose patients to adenomatous polyposis coli/mutY DNA glycosylase mutation-negative familial adenomatous polyposis
por: Liu, Wei Qing, et al.
Publicado: (2018)